Cited by 423Blood Pressure and Hypertension StudiesChronic Kidney Disease and DiabetesSodium Intake and Health

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Hypertension Awareness, Treatment, and Control in Adults With CKD: Results From the Chronic Renal Insufficiency Cohort (CRIC) Study

Open access

Muntner, Paul, Anderson, Amanda, Charleston, Jeanne, Chen, Zhen, Ford, Virginia, Makos, Gail, O'Connor, Andrew, Perumal, Kalyani, Rahman, Mahboob, Steigerwalt, Susan, Teal, Valerie, Townsend, Raymond, Weir, Matthew, Wright, Jackson T.·2010·American Journal of Kidney Diseases

DOI 10.1053/j.ajkd.2009.09.014PMC PMC2866514

Open this paper in CoChat — free account

Abstract

Background A low rate of blood pressure control has been reported in patients with chronic kidney disease (CKD). These data were derived from population-based samples with a low rate of CKD awareness.Study design Cross-sectional.Setting & participants Data from the baseline visit of the Chronic Renal Insufficiency Cohort (CRIC) Study (n = 3,612) were analyzed. Participants with an estimated glomerular filtration rate of 20-70 mL/min/1.73 m(2) were identified from physician offices and review of laboratory databases.Outcomes Prevalence and awareness of hypertension, treatment patterns, control rates, and factors associated with hypertension control.Measurements Following a standardized protocol, blood pressure was measured 3 times by trained staff, and hypertension was defined as systolic blood pressure > or =140 mm Hg and/or diastolic blood pressure > or =90 mm Hg and/or self-reported antihypertensive medication use. Patients' awareness and treatment of hypertension were defined using self-report, and 2 levels of hypertension control were evaluated: systolic/diastolic blood pressure <140/90 and <130/80 mm Hg.Results The prevalence of hypertension was 85.7%, and 98.9% of CRIC participants were aware of this diagnosis and 98.3% were treated with medications, whereas 67.1% and 46.1% had hypertension controlled to <140/90 and <130/80 mm Hg, respectively. Of CRIC participants with hypertension, 15%, 25%, 26%, and 32% were using 1, 2, 3, and > or =4 antihypertensive medications, respectively. After multivariable adjustment, older patients, blacks, and those with higher urinary albumin excretion were less likely, whereas participants using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers were more likely to have controlled their hypertension to <140/90 and <130/80 mm Hg.Limitations Data were derived from a single study visit.Conclusions Despite almost universal hypertension awareness and treatment in this cohort of patients with CKD, rates of hypertension control were suboptimal.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1053/j.ajkd.2009.09.014

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Prevalence of Chronic Kidney Disease in the United States
Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007) · JAMA · doi:10.1001/jama.298.17.2038 · Cited by 4,895
Effect of Aerobic Exercise on Blood Pressure: A Meta-Analysis of Randomized, Controlled Trials
Whelton, S. P., Chin, A., Xin, X., & He, J. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-7-200204020-00006 · Cited by 1,970
Predictors of New-Onset Kidney Disease in a Community-Based Population
Fox, C. S. (2004) · JAMA · doi:10.1001/jama.291.7.844 · Cited by 1,241
Sodium Reduction and Weight Loss in the Treatment of Hypertension in Older Persons: A Randomized Controlled Trial of Nonpharmacologic Interventions in the Elderly (TONE)
Whelton, P. K., Appel, L. J., Espeland, M. A., Applegate, W. B., Ettinger, Jr., Kostis, J. B., Kumanyika, S., Lacy, C. R., Johnson, K. C., Folmar, S., et al. (1998) · JAMA · doi:10.1001/jama.279.11.839 · Cited by 1,200
Effects of Alcohol Reduction on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials
Xin, X., He, J., Frontini, M. G., Ogden, L. G., Motsamai, O. I., & Whelton, P. K. (2001) · Hypertension · doi:10.1161/hy1101.093424 · Cited by 738
The Chronic Renal Insufficiency Cohort (CRIC) Study
Feldman, H. I., Appel, L. J., Chertow, G. M., Cifelli, D., Čižman, B., Daugirdas, J. T., Fink, J. C., Franklin-Becker, E. D., Go, A. S., Hamm, L. L., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000070149.78399.ce · Cited by 660
Self-citation
Prevalence of High Blood Pressure and Elevated Serum Creatinine Level in the United States
Coresh, J., Wei, G. L., McQuillan, G. M., Brancati, F., Levey, A. S., Jones, C. A., & Klag, M. J. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.9.1207 · Cited by 579
Traditional and Nontraditional Risk Factors Predict Coronary Heart Disease in Chronic Kidney Disease
Muntner, P., He, J., Astor, B. C., Folsom, A. R., & Coresh, J. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004080656 · Cited by 490
Self-citation

Show all 16 references

Sorted by citations

Items 201–300 of 423

Factors Associated With Failure to Achieve the Intensive Blood Pressure Target in the Systolic Blood Pressure Intervention Trial (SPRINT)
Wang, K. M., Stedman, M. R., Chertow, G. M., & Chang, T. I. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.16155 · Cited by 10
“A meta-analysis of 61 observational studies in adults aged ≥40 years without known vascular disease found that risk of vascular disease mortality (including ischemic heart disease, stroke, and other conditions) is higher when SBP is >115 mm Hg.18 A direct relation between BP and vascular disease mortality was noted in…”
Background
Effect of Erythropoiesis-Stimulating Agents on Blood Pressure in Pre-Dialysis Patients
Suttorp, M., Hoekstra, T., Mittelman, M., Ott, I., Franssen, C. F. M., & Dekker, F. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084848 · Cited by 10
Prevalence, Awareness, and Treatment of Hypertension in Hispanics/Latinos With CKD in the Hispanic Community Health Study/Study of Latinos
Lora, C., Ricardo, A., Chen, J., Franceschini, N., Kramer, H., Melamed, M., Raij, L., Rosas, S., Schneiderman, N., Daviglus, M., et al. (2020) · Kidney Medicine · doi:10.1016/j.xkme.2020.02.005 · Cited by 9
Interaction effect of blood glucose and pressure on the risk of chronic kidney disease: a population-based prospective cohort study
Wang, M., Xia, M., Yang, H., Zhang, D., Zhao, Y., He, Y., Liu, J., Zhang, L., Yin, C., & Bai, Y. (2022) · Endocrine · doi:10.1007/s12020-022-03094-9 · Cited by 9
The impact of chronic kidney disease on prognosis in acute stroke: unraveling the pathophysiology and clinical complexity for optimal management
Rajesh, K., Spring, K. J., Smokovski, I., Upmanyue, V., Mehndiratta, M. M., Strippoli, G. F., Beran, R. G., & Bhaskar, S. M. M. (2024) · Clinical and Experimental Nephrology · doi:10.1007/s10157-024-02556-w · Cited by 11
Hipertensión arterial en la enfermedad renal crónica
Arroyo, D., Quiroga, B., & de la Fuente, G. D. A. (2019) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2019.06.003 · Cited by 11
Blood Pressure Targets in CKD: Lessons Learned from SPRINT and Previous Observational Studies
Gosmanova, E. O., & Kovesdy, C. P. (2016) · Current Cardiology Reports · doi:10.1007/s11886-016-0769-y · Cited by 9
Synergistic interaction of hyperuricemia and hypertension on reduced eGFR: insights from a general Chinese population
Shi, W., Wang, H., Zhou, Y., Sun, Y., & Chen, Y. (2020) · Postgraduate Medicine · doi:10.1080/00325481.2020.1718387 · Cited by 9
Blood pressure targets in chronic kidney disease
Guerrot, D., & Humalda, J. K. (2020) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000601 · Cited by 9
“On average 86% of patients with CKD have hypertension, compared to 29% of the general population [3,5,6], and the more the GFR decreases, the more the prevalence of hypertension increases [2].”
Background
Outcomes from a community-based hypertension educational programme: the West of Ireland Hypertension study
Darrat, M., Houlihan, A., Gibson, I., Rabbitt, M., Flaherty, G. T., & Sharif, F. (2017) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-017-1706-9 · Cited by 10
Threshold Effects of Serum Uric Acid on Chronic Kidney Disease in US Women without Hypertension and Diabetes: A Cross-Sectional Study
Hu, G.-P., Bai, Y., Chen, T., Tang, S., & Hu, L.-H. (2019) · Kidney & Blood Pressure Research · doi:10.1159/000502183 · Cited by 8
Chronic Kidney Disease
Borrelli, S., Nicola, L. D., Conte, G., & Minutolo, R. (2018) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-59918-2_21 · Cited by 9
Antihypertensive prescribing patterns in non-dialysis dependent chronic kidney disease: Findings from the Salford Kidney Study
Chinnadurai, R., Wu, H. H. L., Abuomar, J., Rengarajan, S., New, D. I., Green, D., & Kalra, P. A. (2023) · World Journal of Nephrology · doi:10.5527/wjn.v12.i5.168 · Cited by 9
Assessment of health-related quality of life in hypertensive hemodialysis patients
Aslam, A., Shah, S., Abbas, G. H., Rehman, A. U., Mallhi, T. H., Alotaibi, N. H., Alzarea, A. I., Rasool, M. F., Khurram, H., Noureen, S., et al. (2022) · PeerJ · doi:10.7717/peerj.12690 · Cited by 8
Hypertension Management in Chronic Kidney Disease and Diabetes
Thomas, G. (2019) · Cardiology Clinics · doi:10.1016/j.ccl.2019.04.006 · Cited by 10
Synergistic interaction of hypertension and hyperhomocysteinemia on chronic kidney disease: Findings from the National Health and Nutrition Examination Survey 1999‐2006
Shi, W., Zhou, Y., Wang, H., Sun, Y., & Chen, Y. (2019) · Journal of Clinical Hypertension · doi:10.1111/jch.13673 · Cited by 8
The impact of pharmacist‐led interventions on blood pressure control among patients with chronic kidney disease: A randomized controlled trial
Okoro, R. N., Ummate, I., Ohieku, J. D., Yakubu, S. I., & Adibe, M. O. (2022) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.1677 · Cited by 9
Rate and Risk Factors of Acute Myocardial Infarction after Debut of Chronic Kidney Disease—Results from the KidDiCo
Kampmann, J. D., Heaf, J. G., Mogensen, C. B., Petersen, S. R., Wolff, D. L., Mickley, H., & Brandt, F. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9110387 · Cited by 8
What should be the blood pressure target for patients with chronic kidney disease?
Nicholas, S. B., Vaziri, N. D., & Norris, K. C. (2013) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32836208c2 · Cited by 8
Management of cardiovascular disease in chronic kidney disease: implications for managed care.
Calabrese, D. (2011) · PubMed · Cited by 8
Procedures and devices to treat resistant hypertension in chronic kidney disease
Gajulapalli, R. D., Chahine, J., Rader, F., & Aneja, A. (2020) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.87a.19099 · Cited by 9
Descriptive Cross‐Sectional Study on Knowledge, Awareness, and Adherence to Medication among Hypertensive Patients at a Tertiary Care Centre in Colombo District, Sri Lanka
Pirasath, S., Sugathapala, A. G. H., & Wanigasuriya, K. P. (2020) · International Journal of Hypertension · doi:10.1155/2020/1320109 · Cited by 9
Incidence, long-term predictors and progression of chronic kidney disease among African migrants and non-migrants: the transcontinental population-based prospective RODAM cohort study
Mungamba, M. M., Chilunga, F. P., van der Linden, E. L., Beune, E., Godwill, E. A., Hayfron-Benjamin, C. F., Meeks, K. A. C., Darko, S. N., Twumasi-Ankrah, S., Owusu‐Dabo, E., et al. (2025) · BMJ Global Health · doi:10.1136/bmjgh-2024-016786 · Cited by 7
Stroke attributed to kidney dysfunction from 1990 to 2021 and the prediction for 2040: an analysis of national data in China based on the Global Burden of Disease 2021 database
Guo, N., Teng, S., Chen, S., Bi, J., Xu, X., Wang, H., Teng, W., & Xue, W. (2025) · BMC Public Health · doi:10.1186/s12889-025-22575-w · Cited by 7
Prevalence, awareness, treatment, and control of hypertension in community-dwelling older adults with chronic kidney disease: the Irish longitudinal study on ageing
Browne, L., Alamin, M., Miri, H. H., Hall, R., Tandan, M., Sexton, D. J., & Stack, A. G. (2024) · Clinical Kidney Journal · doi:10.1093/ckj/sfae184 · Cited by 8
Efficacy and Safety of Finerenone in Patients with Chronic Kidney Disease and Type 2 Diabetes By Diuretic Use: A FIDELITY Analysis
Mentz, R. J., Anker, S. D., Pitt, B., Rossing, P. R., Ruilope, L. M., Gebel, M., Kolkhof, P., Lawatscheck, R., Rohwedder, K., & Bakris, G. L. (2025) · European Journal of Heart Failure · doi:10.1002/ejhf.3569 · Cited by 11
Resistant and undertreated hypertension in patients with chronic kidney disease: data from the PATRIOTIC survey
Zheng, Y., Tang, L. Y., Chen, X., Cai, G., Li, W., Ni, Z., Shi, W., Ding, X., & Lin, H. (2018) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2018.1433193 · Cited by 7
Static and Dynamic Prediction of Chronic Renal Disease Progression Using Longitudinal Clinical Data from Taiwan’s National Prevention Programs
Chang, Y., Liao, C.-M., Wang, L.-H., Hu, H., & Lin, C. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10143085 · Cited by 7
Isolated Diastolic Hypertension and Kidney and Cardiovascular Outcomes in CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study
Alsaleh, S., Dobre, M. A., Delozier, S., Perez, J., Patil, N. T., Rahman, M., & Pradhan, N. (2023) · Kidney Medicine · doi:10.1016/j.xkme.2023.100728 · Cited by 7
Self-citation
Prevalence and factors associated with masked hypertension in chronic kidney disease
Legrand, F., Motiejūnaitė, J., Arnoult, F., Lahens, A., Tabibzadeh, N., Robert, T., Rouzet, F., de Pinho, N. A., Vrtovsnik, F., Flamant, M., et al. (2024) · Journal of Hypertension · doi:10.1097/hjh.0000000000003680 · Cited by 7
SURVEY FOR POTENTIAL RISK FACTORS FOR SUSCEPTIBILITY TO CHRONIC KIDNEY DISEASE IN HAIL REGION, KSA
Ginawi, I., Ahmed, H., Ashankyty, I., Altamimi, T. N., Almogbel, M., Alsuedaa, A., Akbar, D., Albeladi, F., Alrashdan, A., Jastaniah, S., et al. (2013) · Management in Health · doi:10.5233/mih.v17i2.269 · Cited by 9
Pharmacologic Treatment of Hypertension in Patients With Chronic Kidney Disease
Talreja, H., Ruzicka, M., & McCormick, B. B. (2013) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-013-0009-4 · Cited by 10
Th17/Treg cell expression in children with primary nephritic syndrome and the effects of ox-LDL on Th17/Treg cells
Li, Y., Wei, S. G., Zhao, X. D., Jia, Y., Zhang, Y., & Sun, S. (2016) · Genetics and Molecular Research · doi:10.4238/gmr.15027669 · Cited by 7
A feared combination: Hypertension and chronic kidney disease
Varleta, P. E., & Tagle, R. (2018) · Journal of Clinical Hypertension · doi:10.1111/jch.13432 · Cited by 7
Kidney tubule health, mineral metabolism and adverse events in persons with CKD in SPRINT
Ascher, S. B., Scherzer, R., Estrella, M. M., Berry, J. D., de Lemos, J. A., Jotwani, V., Garimella, P. S., Malhotra, R., Bullen, A. L., Katz, R., et al. (2021) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfab255 · Cited by 11
Efficacy and safety of dual vs single renin–angiotensin–aldosterone system blockade in chronic kidney disease
Zhao, M., Qu, H., Wang, R., Yu, Y., Chang, M., Ma, S., Zhang, H., Wang, Y., & Zhang, Y. (2021) · Medicine · doi:10.1097/md.0000000000026544 · Cited by 8
Physical Activity In Renal Disease (PAIRED) and the effect on hypertension: study protocol for a randomized controlled trial
Thompson, S., Wiebe, N., Gyenes, G. T., Davies, R., Radhakrishnan, J., & Graham, M. M. (2019) · Trials · doi:10.1186/s13063-019-3235-5 · Cited by 7
Lower ambulatory nocturnal SBP is associated with less cardiovascular and renal damage in normotensive hospitalized patients with chronic kidney disease
Zhang, J., Song, J., Zhou, L., Zhou, W., Rao, J., Li, Y., Wu, J., Peng, H., & Lou, T. (2021) · Journal of Hypertension · doi:10.1097/hjh.0000000000002930 · Cited by 6
Chronic kidney disease in general populations and primary care
Taal, M. W. (2013) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e328365adf6 · Cited by 6
A Genome-Wide Association Study for Hypertensive Kidney Disease in Korean Men
Kim, H., Jin, H., & Eom, Y. (2021) · Genes · doi:10.3390/genes12050751 · Cited by 6
Drug Utilization Evaluation Study and Dose Adjustment in Patients with Kidney Disease in Tertiary Care Hospital
Mathew, S. V., Uttangi, S., Noble, D., Ravi, M., Mathew, S. K., & Venkatesh, J. (2021) · International Journal of Biomedical Engineering and Clinical Science · doi:10.11648/j.ijbecs.20210703.13 · Cited by 6
Awareness of diagnosis, treatment plan and prognosis among patients attending public hospitals and health centers in Addis Ababa, Ethiopia
Teklu, A. M., Abraha, M., Legesse, T., Bekele, M., Getachew, A., Assefa, B., Molla, M., Belachew, F., & Haregu, T. (2022) · PLoS ONE · doi:10.1371/journal.pone.0270397 · Cited by 6
Hepatic and proximal tubule angiotensinogen play distinct roles in kidney dysfunction, glomerular and tubular injury, and fibrosis progression
Jang, H., Noh, M. R., Plumb, T. J., Lee, K., He, C., Ferrer, F. A., & Padanilam, B. J. (2022) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00029.2022 · Cited by 7
Novel Model of Oxalate Diet-Induced Chronic Kidney Disease in Dahl-Salt-Sensitive Rats
Dube, P. R., Aradhyula, V., Lad, A. C., Khalaf, F. K., Breidenbach, J. D., Kashaboina, E., Gorthi, S., Varatharajan, S., Stevens, T. W., Connolly, J. A., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210062 · Cited by 6
Understanding Cognitive Deficits in People with High Blood Pressure
Kang, W., & Hernández, S. P. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13111592 · Cited by 6
Nephroprotective strategy in the treatment of hypertension as a modern general medical problem
Podzolkov, V. I., Bragina, A. E., Ishina, T. I., Bragina, L. V., & Vasilyeva, L. V. (2018) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2018-12- · Cited by 6
An Automated Blood Pressure Display for Self-Measurement in Patients With Chronic Kidney Disease (iHealth Track): Device Validation Study
Pardo, V. M., Vallejo, R., Losa‐Iglesias, M. E., López‐López, D., Calvo‐Lobo, C., Rodríguez‐Sanz, D., Martínez‐Jiménez, E. M., & Palomo‐López, P. (2020) · JMIR mhealth and uhealth · doi:10.2196/14702 · Cited by 6
Implications of Kidney Disease in the Cardiac Patient
Nicolas, J., Claessen, B. E. P. M., & Mehran, R. (2020) · Interventional Cardiology Clinics · doi:10.1016/j.iccl.2020.03.002 · Cited by 6
Rates of Cardiovascular Disease and CKD Progression in Young Adults with CKD across Racial and Ethnic Groups
Kula, A. J., Prince, D. K., Limonte, C. P., Young, B. A., & Bansal, N. (2022) · Kidney360 · doi:10.34067/kid.0006712021 · Cited by 6
Chronic kidney disease
Hutchison, A. J. (2020) · doi:10.1093/med/9780198746690.003.0478 · Cited by 8
Improvement and influencing factors of blood pressure control by nephrologist referral in chronic kidney disease patients in China: a cohort study
Wang, L., Yin, D., Zhang, D., Xu, R., Cui, W., & Liu, W. (2012) · International Urology and Nephrology · doi:10.1007/s11255-012-0332-8 · Cited by 6
Hypertension and Kidney Disease: What Do the Data Really Show?
Cohen, D. L., & Townsend, R. R. (2012) · Current Hypertension Reports · doi:10.1007/s11906-012-0285-4 · Cited by 6
Self-citation
Epidemiology of Chronic Kidney Disease Among Normotensives
Agarwal, R. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.151811 · Cited by 6
Pulse Pressure and Cardiovascular and Kidney Outcomes by Age in the Chronic Renal Insufficiency Cohort (CRIC)
Fischman, C. J., Townsend, R. R., Cohen, D. L., Rahman, M., Weir, M. R., Juraschek, S. P., South, A. M., Appel, L. J., Drawz, P. E., Cohen, J. B., et al. (2024) · American Journal of Hypertension · doi:10.1093/ajh/hpae136 · Cited by 5
Self-citation
Prognostic value of nighttime blood pressure in patients with chronic kidney disease
Li, J., Qin, W. D., Li, S., Song, J., Wang, C., Zhang, J., & Peng, H. (2025) · Hypertension Research · doi:10.1038/s41440-024-02080-0 · Cited by 5
“The prevalence of hypertension in the patients with CKD was reported to be 86% [3].”
Associations between Multimorbidity and the Risks of Cardiovascular Disease Events and All-Cause Mortality in Patients with Chronic Kidney Disease
Okamura, K., Tanaka, S., Kitamura, H., Suenaga, T., Tsuruya, K., Kitazono, T., & Nakano, T. (2025) · American Journal of Nephrology · doi:10.1159/000544722 · Cited by 5
“For conditions de ﬁ ned by objective criteria, hypertension was de ﬁ ned as blood pressure ≥ 140/90 mm Hg or the use of antihypertensive medications [21], and diabetes mellitus was identi ﬁ ed as hemoglobin A1c values ≥ 6.5% [22], the presence of diabetic nephropathy, or the use of antidiabetic…”
Influential
Kronik Böbrek Yetmezliği Olan Hastalarda Antihipertansif İlaç Tedavisine Uyum Oranları ve Etkileyen Faktörlerin Araştırılması
Yakar, B., & DEMİR, M. (2019) · Dicle Medical Journal / Dicle Tip Dergisi · doi:10.5798/dicletip.661259 · Cited by 5
RNA sequencing reveals induction of specific renal inflammatory pathways in a rat model of malignant hypertension
Menendez‐Castro, C., Cordasic, N., Fahlbusch, F. B., Ekici, A. B., Kirchner, P., Daniel, C., Amann, K., Velkeen, R., Woelfle, J., Schiffer, M., et al. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-021-02133-8 · Cited by 5
CVD risk in non-albuminuric chronic kidney disease in hypertensive, non-diabetic subjects: A post-hoc analysis from SPRINT
Sheng, C., Wang, D., Yuan, J., Cheng, Y., Sun, S., Yang, Y., Miao, Y., Wang, W., Tian, J., & Bloomgarden, Z. T. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.977938 · Cited by 5
Awareness of Hypertension in Reproductive-Aged Women Living With Chronic Kidney Disease
Chang, D. H., Ahmed, S. B., Riehl-Tonn, V. J., Kalenga, C. Z., Sola, D. Y., & Dumanski, S. M. (2023) · CJC Open · doi:10.1016/j.cjco.2023.12.006 · Cited by 5
“12 Further, in 1 study, hypertension awareness was highest in those with stage 3 to 4 CKD (67”
BackgroundResultInfluential
Pharmacotherapy of hypertension in patients with pre-dialysis chronic kidney disease
Loutradis, C., & Sarafidis, P. A. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1726318 · Cited by 5
Serum Metabolites Associated with Blood Pressure in Chronic Kidney Disease Patients
Yan, F., Chen, D., Tang, J., Zhao, Y., & Guo, Y. P. (2022) · Metabolites · doi:10.3390/metabo12040281 · Cited by 5
Antihypertensive Treatment Patterns in CKD Stages 3 and 4: The CKD-REIN Cohort Study
Costes-Albrespic, M., Liabeuf, S., Laville, S. M., Jacquelinet, C., Combe, C., Fouque, D. P., Laville, M., Frimat, L., Pecoits‐Filho, R., Lambert, O., et al. (2024) · Kidney Medicine · doi:10.1016/j.xkme.2024.100912 · Cited by 5
Exposure to per- and polyfluoroalkyl substances (PFAS) and phthalate metabolites and their association with low estimated glomerular filtration rates in the US population
Rahman, H. H., Stokey, W. R., & Munson‐McGee, S. H. (2025) · Food and Chemical Toxicology · doi:10.1016/j.fct.2025.115853 · Cited by 4
Health Literacy, Self-Care Behaviors, and Biochemical Parameters Among Hypertensive Patients with Renal Complications in the Tai Lue Ethnic Community of Thailand
Sriprachot, N., Seangpraw, K., & Ong-artborirak, P. (2024) · Vascular Health and Risk Management · doi:10.2147/vhrm.s450775 · Cited by 7
The renin-angiotensin-aldosterone system in kidney diseases of cats and dogs
Huang, J., Lourenço, B. N., & Coleman, A. E. (2024) · The Veterinary Journal · doi:10.1016/j.tvjl.2024.106287 · Cited by 4
Trends in risk factor control and treatment among patients with non‐alcoholic fatty liver disease and type 2 diabetes between 2000 and 2020: A territory‐wide study
Zhang, X., Yip, T. C., Tse, Y., Hui, V. W., Li, G., Lin, H., Liang, L. Y., Lai, J. C., Lai, M. S., Cheung, J. T. K., et al. (2023) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17428 · Cited by 4
Association between chronic kidney disease stages and changes in ambulatory blood pressure monitoring parameters
Nagahama, A. M., Silva, V. D. S., Banin, V. B., Franco, R. J. D. S., Barretti, P., Bazan, S. G. Z., & Martín, L. C. (2024) · Brazilian Journal of Nephrology · doi:10.1590/2175-8239-jbn-2023-0066en · Cited by 4
Complex patterns and determinants of regional multiple chronic conditions across the United States
Xu, Y., Yan, M., Fu, C., Xu, W., Liu, Y., & Li, Y. (2024) · PNAS Nexus · doi:10.1093/pnasnexus/pgae513 · Cited by 6
Significance of past history of renal failure for the detection of high-risk individuals for cardiovascular and end-stage renal disease: analysis of data from a nationwide health checkup
Ichikawa, K., Konta, T., Ikeda, A., Fujimoto, S., Iseki, K., Moriyama, T., Yamagata, K., Tsuruya, K., Yoshida, H., Asahi, K., et al. (2011) · Clinical and Experimental Nephrology · doi:10.1007/s10157-011-0509-y · Cited by 4
“An Italian study reported that the evaluation and treatment of kidney disease by general physicians was likely to be suboptimal [14, 15 ].”
Background
Hypertension Treatment for Patients with Advanced Chronic Kidney Disease
Sinha, A. D., & Agarwal, R. (2014) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-014-0400-y · Cited by 4
Effectiveness and Tolerability of Nifedipine GITS in Patients with Chronic Kidney Disease and Uncontrolled Hypertension: A Prospective, Multicenter, Observational Study (ADRENAL)
Lv, R., Chen, J.-H., Wang, H.-M., Wang, J., Cheng, H., Li, R., Li, W., Zhang, T., Wei, L., Chen, Q.-K., et al. (2021) · Advances in Therapy · doi:10.1007/s12325-021-01850-3 · Cited by 4
Secondary hypertension: evaluation and management
Tandan, N., Lavie, C. J., Stewart, M. H., Milani, R. V., & Ventura, H. O. (2023) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000001059 · Cited by 5
Blood selenium level can alleviate the nephrotoxicity of lead and cadmium in the general population of the United States: a retrospective cross section analysis of population‐based nationally representative data
Shi, Y., Hu, H., Wu, Z., Chen, Z., & Li, P. (2023) · Environmental Science and Pollution Research · doi:10.1007/s11356-023-27663-1 · Cited by 4
Self-citation
Blood pressure control and satisfaction of hypertensive patients following a switch to combined drugs of an angiotensin receptor blocker and a calcium channel blocker in clinical practice of nephrology
Kato, H., Shiraishi, T., Ueda, S., Kubo, E., Shima, T., Nagura, M., Yano, H., Izumikawa, Y., Shimada, M., Tomioka, S., et al. (2014) · Clinical and Experimental Nephrology · doi:10.1007/s10157-014-1017-7 · Cited by 5
Time to Initiation of Antihypertensive Therapy After Onset of Elevated Blood Pressure in Patients With Primary Proteinuric Kidney Disease
Weaver, D. J., Waldo, A., Oh, G. J., Kamil, E. S., Elliott, M., Adler, S. G., Pesenson, A., Modes, M., Gipson, P. E., Lafayette, R. A., et al. (2020) · Kidney Medicine · doi:10.1016/j.xkme.2019.10.012 · Cited by 4
Carotid artery stiffness mechanisms, heart failure events, and atrial fibrillation in MESA: the Multi-Ethnic Study of Atherosclerosis
Pewowaruk, R. J., Korcarz, C. E., Bluemke, D. A., Hamdan, M. H., Heckbert, S. R., Lima, J. A. C., Tedla, Y. G., & Gepner, A. D. (2025) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00047.2025 · Cited by 3
Management of drug-resistant hypertension as a heterogeneous disorder
Tabrizchi, R. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108875 · Cited by 4
Application of the American Heart Association/American College of Cardiology/Heart Failure Society of America Heart Failure Staging Guidelines in Adults With Chronic Kidney Disease
Zemke, A. M., Zelnick, L. R., Ix, J. H., Go, A. S., Siew, E. D., & Bansal, N. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.039868 · Cited by 3
Enfermedad renal crónica (I). Etiopatogenia, manifestaciones clínicas, diagnóstico y pronóstico
Giraldo, Y. G., Fernández, E., Muñoz, R. G., López, C. M. D., & Bouarich, H. (2023) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2023.05.012 · Cited by 6
Effect of Tissue-derived Angiotensinogen on Kidney Injury and Fibrosis in Obstructive Nephropathy
Jang, H., Noh, M. R., Ha, L., Kim, J., & Padanilam, B. J. (2024) · In Vivo · doi:10.21873/invivo.13672 · Cited by 3
Peroxiredoxin 5 Acts as a Negative Regulator of the Sodium-Chloride Cotransporter Involved in Alleviating Angiotensin II-Induced Hypertension
Choi, H., Jung, I. M., & Kim, S. W. (2025) · Antioxidants · doi:10.3390/antiox14010100 · Cited by 3
Hypertension and Cardiovascular Disease in Patients with Chronic Kidney Disease
Hamrahian, S. M. (2021) · Springer eBooks · doi:10.1007/978-3-030-83082-3_15 · Cited by 4
Type II Diabetes as the Main Risk Factor of Arterial Stiffness in Chronic Kidney Disease Patients
Susilo, H., Alsagaff, M. Y., Pikir, B. S., Thaha, M., & Wungu, C. D. K. (2022) · International Conference on Medical and Health Informatics (ICMHI) · doi:10.1145/3545729.3545771 · Cited by 3
Angiotensin II receptor blockers and bone fracture in chronic kidney disease patients: the Fukuoka kidney disease Registry Study
Shukuri, T., Nakai, K., Tanaka, S., Yamada, S., Tokumoto, M., Tsuruya, K., Nakano, T., & Kitazono, T. (2023) · Clinical and Experimental Nephrology · doi:10.1007/s10157-023-02385-3 · Cited by 3
New Potential Treatments for Resistant Hypertension
Janakiraman, A., & Cohen, D. L. (2023) · Current Cardiology Reports · doi:10.1007/s11886-023-01966-8 · Cited by 3
Renal dysfunction in HIV-infected patients commencing antiretroviral therapy in a treatment centre in southern Nigeria
Tamuno, I., Emem-Chioma, P., & Tamunobelema, T. I. (2024) · Babcock University Medical Journal · doi:10.38029/babcockuniv.med.j..v7i1.327 · Cited by 3
Pathogenesis and Prevention of Progression of Chronic Kidney Disease
Mandal, A. K. (2015) · Open Journal of Internal Medicine · doi:10.4236/ojim.2015.53010 · Cited by 3
Current antihypertensive treatment and treatment-resistant hypertension in Japanese patients with chronic kidney disease
Tsuchimoto, A., Tanaka, S., Kitamura, H., Hiyamuta, H., Tsuruya, K., Kitazono, T., Nakano, T., Fujimi, S., Hirakata, H., Hirano, T., et al. (2022) · Clinical and Experimental Nephrology · doi:10.1007/s10157-022-02250-9 · Cited by 3
Usefulness of Telemetric Blood Pressure Monitoring in Hypertensive Patients with Chronic Kidney Diseases
Burnier, M. (2012) · Journal of Nephrology & Therapeutics · doi:10.4172/2161-0959.1000122 · Cited by 3
Hypertension-Chronic Kidney Disease Relationships
Berbari, A. E., & Daouk, N. A. (2017) · Nephrology - Open Journal · doi:10.17140/npoj-3-e009 · Cited by 3
More From SPRINT (Systolic Blood Pressure Intervention Trial): A Closer Look at the Price of Intensive Blood Pressure Control
Taler, S. J. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2017.11.008 · Cited by 3
Management of Hypertension in Chronic Kidney Disease
Cohen, J. B., & Townsend, R. R. (2016) · Springer eBooks · doi:10.1007/978-1-4939-6436-9_10 · Cited by 3
Self-citation
Gambaran Komplikasi Penyakit Ginjal Kronik Non Dialisis di Poliklinik Ginjal-Hipertensi RSUP Prof. Dr. R. D. Kandou Periode Januari 2017 – Desember 2018
Karinda, T. U. S., Sugeng, C. E. C., & Moeis, E. S. (2019) · e-CliniC · doi:10.35790/ecl.v7i2.26878 · Cited by 3
Management of arterial hypertension in patients with chronic kidney disease on hemodialysis
Батюшин, М. М. (2022) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2022-28-6-627-640 · Cited by 3
Association between alpha blocker use and the risk of fractures in patients with chronic kidney disease: a cohort study
Sunohara, K., Onogi, C., Tanaka, A., Furuhashi, K., Matsumoto, J., Hattori, K., Owaki, A., Kato, A., Kawazoe, T., Watanabe, Y., et al. (2024) · BMC Nephrology · doi:10.1186/s12882-024-03892-5 · Cited by 2
Improving Blood Pressure in High-Risk Patients With CKD Using an Interdisciplinary Remote Hypertension Program
Fisher, M. C., Rikin, S., Gupta, S., Awori, J., Terzibachi, M., Sebastian, G., Stark, A., & Johns, T. S. (2025) · Kidney International Reports · doi:10.1016/j.ekir.2025.01.028 · Cited by 5
A clinical trial evaluating pharmacist-guided self-management of hypertension among veterans with CKD, rationale and study design
Good, M. K., Hoskins, R., Lund, B. C., Eyck, P. T., Dixon, B. S., Cohen, J. B., Reisinger, H. S., Kennelty, K. A., & Jalal, D. I. (2025) · Contemporary Clinical Trials · doi:10.1016/j.cct.2025.107950 · Cited by 2
Accuracy of Identification of Cardiovascular Events with International Classification of Diseases Diagnosis Codes versus Physician Adjudication in CKD and Kidney Failure
Zemke, A. M., Zelnick, L. R., de Boer, I. H., Kestenbaum, B. R., Go, A. S., & Bansal, N. (2025) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000874 · Cited by 2
Stroke risk associated with chronic kidney disease
Yusupov, F. A., Yusupov, A. F., & Yuldashev, A. A. (2025) · Urology Herald · doi:10.21886/2308-6424-2025-13-4-97-106 · Cited by 2

Authors: Muntner, P., Anderson, A., Charleston, J., Chen, Z., Ford, V., Makos, G., O'Connor, A., Perumal, K., Rahman, M., Steigerwalt, S., Teal, V., Townsend, R., Weir, M., & Wright, J. T.
Affiliations: University of Alabama at Birmingham (US)
University of Pennsylvania (US)
University of Maryland, Baltimore (US)
National Institutes of Health (US)
University of Illinois Chicago (US)
University Hospitals Cleveland Medical Center (US)
St. John Medical Center (US)
Case Western Reserve University (US)
Corresponding author: Muntner, Paul
ORCID: Muntner, Paul
Anderson, Amanda
Charleston, Jeanne
Chen, Zhen
Rahman, Mahboob
Teal, Valerie
Townsend, Raymond
Wright, Jackson T.
Venue: American Journal of Kidney Diseases
Publisher: Elsevier BV
Published: 2010-03
Volume: 55
Issue: 3
Pages: 441-451
ISSN: 0272-6386 (ISSN-L)
DOI: 10.1053/j.ajkd.2009.09.014
PMC: PMC2866514
OpenAlex: W2096512601
Cited by: 423
References: 16
Citations by year: 2026: 10 · 2025: 34 · 2024: 32 · 2023: 45 · 2022: 34 · 2021: 35 · 2020: 33 · 2019: 40 · 2018: 32 · 2017: 23 · 2016: 20 · 2015: 19 · 2014: 13 · 2013: 16 · 2012: 17
FWCI: 7.55
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: American Journal of Kidney Diseases (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases (5U01DK06102, U01DK060990, 5U01 DK60980, T32DK007785, T32DK060455, K01DK064860, U01DK060984, U01DK060902, U01DK060980, U01DK060963, U01DK061021, U01DK061028)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
Keywords: hypertension, chronic kidney disease, blood pressure control, hypertension awareness, antihypertensive medication use, ACE inhibitors, angiotensin receptor blockers, urinary albumin excretion, Chronic Renal Insufficiency Cohort Study, older adults, racial disparities
MeSH terms: Adult, Aged, Chronic Disease, Female, Humans, Hypertension, Kidney Diseases, Male, Middle Aged, Renal Insufficiency, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Hypertension Awareness, Treatment, and Control in Adults With CKD: Results From the Chronic Renal Insufficiency Cohort (CRIC) Study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks